Skip to main content
. 2023 Oct 24;13(11):1567. doi: 10.3390/biom13111567

Table 1.

List of participants included in this study. Comparison of pathogenic 4q35A allele characteristics using SB and OGM as well as details on the specimen stability used in OGM. Optical genome mapping was performed on specimens stored and processed under two representative conditions: 7 days (d) post-collection and subsequent extraction for Indian samples, and 1 day (d) post-collection and subsequent extraction for UK samples. Four additional samples were tested using archived agarose plugs. SB results were compared with those of OGM. N50 (>0.2) is used as a surrogate marker of molecule size; N50 values represent weighted average lengths of DNA molecules that are 20 Kbp or longer. Map rate (%) indicates the percentage of molecules 150 Kbp or longer that map to the reference genome. Effective coverage indicates the total amount of aligned molecules divided by the length of the reference genome multiplied by the map rate. SB-LGE: Southern blot and Linear Gel Electrophoresis; SB-PFGE: Southern blot and Pulsed-Field Gel Electrophoresis; NA; not analysed; ND: not detected, assumed to be >48 Kb; Methylation FSHD2 thresholds: delta1 ≤ 20%.

Specimen ID # Source Methylation SB-LGE SB-PFGE OGM Shipping/Storing Molecules ≥ 150 Kbp N50 > 0.2 Map Rate (%) Effective Coverage
4q_1 Outcome 4q_1 4q_2 Outcome 4q_1 4q_2 Outcome
FseI (delta1) * U U A/B U A/B U A/B U A/B
NHNN_FSH001 UK NA >10 No F1 No F2 23 B 24 B Negative 23 B 24 B No F1, No F2 d1, −80 °C 332 0.277 94 166×
NHNN_FSH002 UK NA 7 FSHD1 NA NA NA NA - 7 A 49 A FSHD1 d1, −80 °C 304 0.248 95 151×
NHNN_FSH003 UK NA 6 FSHD1 NA NA NA NA - 6 A 39 A FSHD1 d1, −80 °C 382 0.340 93 147×
NHNN_FSH004 UK NA 8 FSHD1 NA NA NA NA - 7 A 29 A FSHD1 d1, −80 °C 242 0.186 91 142×
NHNN_FSH005 UK NA >10 FSHD2 NA NA NA NA - 18 A 24 B FSHD2 d1, −80 °C 293 0.228 65 106×
NHNN_FSH006 UK NA 1 FSHD1 # NA NA NA NA - [1(64%);43(36%)] A 26 B FSHD1 mosaic d1, −80 °C 258 0.198 91 172×
NHNN_FSH007 UK NA 5 FSHD1 NA NA NA NA - 5 A 27 B FSHD1 d1, −80 °C 220 0.158 88 145×
NHNN_FSH008 UK −13 11 No F1, No F2 10 A 10 A FSHD1 ^ 10 A 10 A FSHD1 ^ d1, −80 °C 213 0.143 79 122×
NHNN_FSH009 UK NA 8 FSHD1 NA NA NA NA - 7 A 18 A FSHD1 d1, −80 °C 203 0.120 75 83×
NHNN_FSH010 UK NA >10 No F1, No F2 13 + 6 A 22 A FSHD dup 13 + D A 22 A FSHD dup d1, −80 °C 203 0.142 83 131×
IC_AIM_000950 India 0 NA - 12 B 43 A No F1, No F2 12 B 42 A No F1, No F2 4 °C, d7, −80 °C 251 0.131 80 134×
IC_AIM_000918 India NA NA - 2 A 23 B FSHD1 2 A 23 B FSHD1 4 °C, d7, −80 °C 237 0.126 81 136×
IC_AIM_000955 India NA NA - 5 A 22 A FSHD1 4 A 22 A FSHD1 4 °C, d7, −80 °C 228 0.118 74 105×
IC_AIM_000957 India NA NA - 5 A 39 A FSHD1 4 A 38 A FSHD1 4 °C, d7, −80 °C 249 0.103 77 123×
IC_AIM_000904 India NA NA - 3 A 24 B FSHD1 3 A 24 B FSHD1 4 °C, d7, −80 °C 220 0.094 67 107×
IC_AIM_000963 India NA NA - 4 A 25 A FSHD1 4 A 25 A FSHD1 4 °C, d7, −80 °C 270 0.158 83 132×
IC_AIM_000932 India −35 NA - 9 A 12 B FSHD2 9 A 12 B FSHD2 4 °C, d7, −80 °C 236 0.105 80 122×
IC_AIM_001042 India −41 NA - 19 A 19 A FSHD2 20 A 20 A FSHD2 4 °C, d7, −80 °C 221 0.090 38 62×
IC_AIM_001045 India NA NA - 5 A 25 B FSHD1 4 A 25 B FSHD1 4 °C, d7, −80 °C 213 0.100 64 112×
IC_AIM_001053 India NA NA - 4 A 21 B FSHD1 3 A 21 B FSHD1 4 °C, d7, −80 °C 235 0.147 78 123×
IC_AIM_001055 India NA NA - 6 A 25 A FSHD1 7 A >11 ND FSHD1 4 °C, d7, −80 °C 185 0.083 42 66×
IC_AIM_000820 India NA NA - 4 A 23 + 6 AD FSHD1 3 A 24 + D A FSHD1 4 °C, d5 212 0.161 78 51×
IC_AIM_00152 India 16 NA - 28 A 59 + 3 AD FSHD dup 26 A 61 + D A FSHD dup 4 °C, d5 289 0.234 88 102×
IC_AIM_000701 India NA NA - [2(40%);20(60%)] A 10 B FSHD1 mosaic [2(36%);21(64%)] A 10 B FSHD1 mosaic 4 °C, d5 260 0.177 80 128×
IC_AIM_000531 India −8 NA - 17 B 20 A No F1, No F2 17 B 21 A No F1, No F2 4 °C, d5 250 0.167 74 89×

* delta1 values represent repeat size-corrected D4Z4 methylation calculated as described in Lemmers et al. 2014 [17]. # mosaicism character of the FSHD1 allele was not identified by SB-LGE in sample NHNN_FSH006. ^ homozygous 10 U. NHNN_FSHD008 has a phenotype consistent with FSHD (facial weakness; shoulder and pelvic girdle weakness) and was found to contain Homozygous 10 U via OGM.